GSK3206640A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3206640A, covering 2017-05-30 to 2017-05-30. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age [Phase 1]